Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

13.85 -0.02 (-0.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
1 Unprofitable Stock on Our Buy List and 2 We Brush Off
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Artificial Intelligence Economy
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Preview: Dentsply Sirona
 
Via Benzinga
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. 
Via StockStory
Topics Bonds Economy Stocks
Dentsply Sirona Maintains Outlook Despite Sales Decline
Dentsply Sirona beat Q2 EPS and sales forecasts, drove margin expansion and EBITDA growth, reaffirmed FY25 guidance despite mixed segment performance and a share pullback. 
Via Benzinga
Dentsply Sirona’s (NASDAQ:XRAY) Q2 Earnings Results: Revenue In Line With Expectations
Dental products company Dentsply Sirona (NASDAQ:XRAY) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 4.9% year on year to $936 million. The company’s outlook for the full year... 
Via StockStory
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Via The Motley Fool
Topics Economy
Dentsply Sirona (XRAY) Q2 Earnings Report Preview: What To Look For
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be announcing earnings results this Thursday before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
G-III, Tecnoglass, MYR Group, Jabil, and Dentsply Sirona Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. 
Via StockStory
Topics Stocks World Trade
Forecasting The Future: 4 Analyst Projections For Dentsply Sirona
 
Via Benzinga
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed. 
Via Investor's Business Daily
Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know
Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) jumped 3.5% in the morning session after the company announced the appointment of a new CEO, released positive preliminary second-quarter... 
Via StockStory
Topics Government World Trade
3 Value Stocks with Questionable Fundamentals
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Dental Equipment & Technology Stocks Q1 Results: Benchmarking Envista (NYSE:NVST)
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Envista (NYSE:NVST) and its peers. 
Via StockStory
3 Small-Cap Stocks in Hot Water
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Dental Equipment & Technology Q1 Earnings: Dentsply Sirona (NASDAQ:XRAY) Simply the Best
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the dental equipment & technology industry, including Dentsply Sirona (NASDAQ:XRAY) and its peers. 
Via StockStory
Lifshitz Law PLLC Announces Investigations of Flux Power Holdings, Inc. (NASDAQ:FLUX), PACS Group, Inc. (NYSE:PACS), Dentsply Sirona Inc. (NASDAQ:XRAY), And Customers Bancorp, Inc. (NYSE:CUBI)
Via ACCESS Newswire
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
 
Via Benzinga
Lifshitz Law PLLC Announces Investigations of PACS Group, Inc. (NYSE: PACS), Dentsply Sirona Inc. (NASDAQ: XRAY), Customers Bancorp, Inc. (NYSE: CUBI), and ASP Isotopes Inc. (NASDAQ: ASPI)
Via ACCESS Newswire
3 Cash-Producing Stocks with Bad Fundamentals
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
3 Low-Volatility Stocks in Dangerous Territory
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
XRAY Q1 Earnings Call: Margin Gains Amid Tariff and Market Pressures
Dental products company Dentsply Sirona (NASDAQ:XRAY) beat Wall Street’s revenue expectations in Q1 CY2025. Its non-GAAP EPS of $0.43 per share was 43% above analysts’ consensus estimates. 
Via StockStory
Topics World Trade
Luxfer, LGI Homes, QuidelOrtho, Dentsply Sirona, and AdaptHealth Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +2.0%) as President Trump postponed the planned 50% tariff on European Union imports,... 
Via StockStory
Topics Government Stocks World Trade
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
 
Via Benzinga
Winners And Losers Of Q1: Align Technology (NASDAQ:ALGN) Vs The Rest Of The Dental Equipment & Technology Stocks
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Align Technology (NASDAQ:ALGN) and its peers. 
Via StockStory
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.